Kits Eyecare Announces Normal Course Issuer Bid, With Nod From Toronto Stock Exchange

Published on June 3, 2026
VANCOUVER, B.C.—Kits Eyecare Ltd. (TSX: KITS), a leading vertically integrated eyecare provider based in Canada, has announced that the Toronto Stock Exchange has accepted its notice of intention to make a normal course issuer bid (NCIB) to purchase a portion of its common shares. Under the NCIB, the company may repurchase up to 1,695,313 shares, according to the announcement, representing 5 percent of its issued and outstanding share capital. Any repurchased shares under the bid will be cancelled. As of May 22, 2026, the company had 33,906,264 issued and outstanding common shares.
Continue reading on website
Other news

SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing

June 3, 2026
ALISO VIEJO, Calif.—SpyGlass Pharma, Inc. (Nasdaq: SGP), a late-stage biopharmaceutical company focused on transforming treatment paradigms for patients with chronic eye conditions, has announced the appointment of Mike Pinder as vice president, marketing, effective May 18, 2026. Pinder brings more than 20 years of commercial launch experience in ophthalmology, focused on building, launching and e

Annual General Meeting of EssilorLuxottica Grants Dividend Option to Shareholders

June 3, 2026
PARIS—EssilorLuxottica (Reuters: ESLX.PA) announced on June 1 that its annual general meeting has decided to grant shareholders the option to receive their dividend in shares at a price of €175.06 per share. The company advised this price corresponds to 90 percent of the average of the opening prices quoted on Euronext Paris over the twenty trading days preceding the date of the meeting, less the